Clinical Trial Update: Prevention of Anthracycline-induced Cardiotoxicity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on prevention of anthracycline-induced cardiotoxicity in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Cancer | Phase 3 | Status: UNKNOWN